Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
neurodegenerative diseases
Biotech
Vaxxinity retreats from 'abusive relationship' of public market
Vaxxinity is choosing transparency about the “abusive relationship” that defined the immunotherapy company’s three-year stint as a public company.
Annalee Armstrong
May 15, 2024 9:59am
Labcorp, Quest add new blood tests for Alzheimer's, brain damage
Apr 22, 2024 2:17pm
Amylyx stock slips 6% after phase 2 rare disease data drop
Apr 10, 2024 2:48pm
Gene inhibition prevents types of brain damage in mice, cells
Apr 8, 2024 7:20am
Gain's clinical Parkinson's drug restores motor function in mice
Feb 6, 2024 8:00am
Roche previews Alzheimer's drug that 'drops plaque like a stone'
Feb 1, 2024 11:30am